The economic impact of chronic fatigue syndrome

被引：170

作者：

Reynolds K.J. ^{[1
]}

Vernon S.D. ^{[2
]}

Bouchery E. ^{[3
]}

Reeves W.C. ^{[2
]}

机构：

[1] SRA International Inc., Arlington, VA

[2] Division of Viral/Rickettsial Dis., Centers for Dis. Control/Prevention, Atlanta, GA

[3] The Lewin Group, Falls Church, VA

来源：

Cost Effectiveness and Resource Allocation | / 2卷 / 1期

关键词：

Chronic Fatigue Syndrome; Productivity Loss; Household Productivity; Chronic Fatigue Syndrome Patient; Human Capital Approach;

D O I：

10.1186/1478-7547-2-4

中图分类号：

学科分类号：

摘要：

Background: Chronic fatigue syndrome (CFS) is a chronic incapacitating illness that affects between 400,000 and 800,000 Americans. Despite the disabling nature of this illness, scant research has addressed the economic impact of CFS either on those affected or on the national economy. Methods: We used microsimulation methods to analyze data from a surveillance study of CFS in Wichita, Kansas, and derive estimates of productivity losses due to CFS. Results.We estimated a 37% decline in household productivity and a 54% reduction in labor force productivity among people with CFS. The annual total value of lost productivity in the United States was $9.1 billion, which represents about $20,000 per person with CFS or approximately one-half of the household and labor force productivity of the average person with this syndrome. Conclusion.Lost productivity due to CFS was substantial both on an individual basis and relative to national estimates for other major illnesses. CFS resulted in a national productivity loss comparable to such losses from diseases of the digestive, immune and nervous systems, and from skin disorders. The extent of the burden indicates that continued research to determine the cause and potential therapies for CFS could provide substantial benefit both for individual patients and for the nation. © 2004 Reynolds et al; licensee BioMed Central Ltd.

引用

页数：9

共 20 条

[11]

Rice D.P., Estimating the cost of illness, Am. J. Public Health Nations Health, 57, pp. 424-440, (1967)

[12]

Rice D.P., Cooper B.S., The economic value of human life, Am. J. Public Health Nations Health, 57, pp. 1954-1966, (1967)

[13]

Rice D.P., Hodgson T.A., Kopstein A.N., The economic costs of illness, a replication and update, Health Care Financ. Rev., 7, pp. 61-80, (1985)

[14]

Newhouse J.P., The Health Insurance Group. Free-for-all: Health insurance, medical costs, and health outcomes: The results of the health insurance experiment, (1993)

[15]

Manning W.G., Newhouse J.P., Duan N., Keeler E.B., Leibowitz A., Marquis M.S., Health insurance and the demand for medical care: Evidence from a randomized experiment, Am. Econ. Rev., 77, pp. 251-277, (1987)

[16]

Duan N., Manning W.G., Morris C., Newhouse J.P., A comparison of alternative models for the demand for medical care, J. Bus. Stat., 1, pp. 115-126, (1983)

[17]

Duan N., Manning W.G., Morris C., Newhouse J.P., Choosing between the sample-selection model and the multi-part model, J. Business Econ. Stat., 2, pp. 283-289, (1984)

[18]

Manning W.G., Duan N., Rogers W., Monte Carlo evidence on the choice between sample selection and two-part models, J. Econometrics, 35, pp. 59-82, (1987)

[19]

Rizzo J.A., Abbott III T.A., Berger M.L., The labor productivity effects of chronic backache in the United States, Med. Care, 36, pp. 1471-1488, (1998)

[20]

Reyes M., Gary Jr. H.E., Dobbins J.G., Randall B., Steele L., Fukuda K., Holmes G.P., Et al., Surveillance for chronic fatigue syndrome - Four U.S. cities, September 1989 through August 1993, MMWR CDC Surveill. Summ., 46, pp. 1-13, (1997)

← 1 2 →